Mannatech Secures Second Injunction To Protect Glyconutrient Products

Mannatech has secured a second injunction in its ongoing efforts to protect its glyconutrient products – Ambrotose complex and Advanced Ambrotose formula.

The company said that the US District Court for the Northern District of Texas, Dallas Division, has entered a final judgment and permanent injunction against Boston Mountain Laboratories, which bans it from manufacturing or selling BML Glyconutrient Formula, Glyco-8, Glycoessentials, Glyco-Essence, Glyconutrients, MG-3, and MG-3c for the duration of Mannatech’s US Patents 6,929,807; 7,157,431; 7,196,064; 7,199,104; and 7,202,220.

The courts have recognized that Mannatech is the rightful owner of the patented technology concerning Compositions of Plant Technology as Dietary Supplements.

The company said that as part of the final judgment in the case, Boston Mountain, along with its officers, agents, employees, and any persons acting in concert or participation with the company, are prohibited from making, using, selling, or otherwise distributing any of the accused products or any colorable imitations thereof.

Keith Clark, senior vice president and general counsel of Mannatech, said: “Mannatech has demonstrated that it will fight to protect its intellectual property. The Court’s decision is further notice to all interested parties that we will do what is necessary to support our products and our independent sales Associates in the field.”

Mannatech, Incorporated develops health, weight and fitness, and skin care products that are based on the foundation of nutritional science and development standards. These proprietary products are available through independent sales associates around the globe including the US, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the UK, Japan, Taiwan, Singapore and the Republic of Korea.